[Epidemiology of maternal-fetal group B streptococcal infections]. / Épidémiologie des infections materno-fÅtales à streptocoque du groupe B.
Med Mal Infect
; 41(3): 123-5, 2011 Mar.
Article
em Fr
| MEDLINE
| ID: mdl-21051165
ABSTRACT
GOAL The aim of this study was to determine the incidence, risk factors, and outcome of maternal-fetal infection due to group B streptococcus. PATIENTS AND METHODS:
We identified all cases of maternal-fetal group B streptococcus infection between January 2003 and December 2007, from neonatal unit reports at the Charles Nicolle Hospital.RESULTS:
Ninety cases were identified out of 17,922 live births, incidence 5 of which 2.3 of bacteremia. Twenty percent of all newborns were premature and 22.2% had a low birth weight. Peripartum maternal fever was recorded in 52.2% of cases and membrane rupture more than 12 hours before delivery occurred in 74.4%. Among the newborns, 45.6% were symptomatic at birth. Forty percent of group B streptococci were resistant to erythromycin and 3.3% with intermediate resistance to ampicillin. The global neonatal mortality after group B streptococcus infection was 3.3%.CONCLUSION:
Maternal-fetal infection due to group B streptococcus is still frequent and continues to be a major cause of morbidity and mortality.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Complicações Infecciosas na Gravidez
/
Infecções Estreptocócicas
/
Streptococcus agalactiae
/
Transmissão Vertical de Doenças Infecciosas
Tipo de estudo:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prevalence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Idioma:
Fr
Ano de publicação:
2011
Tipo de documento:
Article